Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1998 1
2001 1
2002 1
2004 1
2005 1
2006 1
2010 1
2012 2
2013 2
2014 2
2015 1
2016 1
2017 1
2021 3
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Retinitis pigmentosa 64"
Page 1
4-Hydroxybutyric aciduria.
Rahbeeni Z, Ozand PT, Rashed M, Gascon GG, al Nasser M, al Odaib A, Amoudi M, Nester M, al Garawi S, Brismar J. Rahbeeni Z, et al. Brain Dev. 1994 Nov;16 Suppl:64-71. doi: 10.1016/0387-7604(94)90098-1. Brain Dev. 1994. PMID: 7726383
The clinical findings in six patients from three families with 4-hydroxybutyric aciduria are described. ...All infants presented with severe global delay and severe hypotonia, and all patients had seizure disorder. Eye findings included optic atrophy in two patients, and …
The clinical findings in six patients from three families with 4-hydroxybutyric aciduria are described. ...All infants presented with …
Nerve Growth Factor: A Focus on Neuroscience and Therapy.
Aloe L, Rocco ML, Balzamino BO, Micera A. Aloe L, et al. Curr Neuropharmacol. 2015;13(3):294-303. doi: 10.2174/1570159x13666150403231920. Curr Neuropharmacol. 2015. PMID: 26411962 Free PMC article. Review.
Recently, the therapeutic property of NGF has been demonstrated on human cutaneous and corneal ulcers, pressure ulcer, glaucoma, maculopathy and retinitis pigmentosa. NGF eye drops administration is well tolerated, with no detectable clinical evidence of syst …
Recently, the therapeutic property of NGF has been demonstrated on human cutaneous and corneal ulcers, pressure ulcer, glaucoma, maculopathy …
Retinitis pigmentosa-associated cystoid macular oedema: pathogenesis and avenues of intervention.
Strong S, Liew G, Michaelides M. Strong S, et al. Br J Ophthalmol. 2017 Jan;101(1):31-37. doi: 10.1136/bjophthalmol-2016-309376. Epub 2016 Dec 2. Br J Ophthalmol. 2017. PMID: 27913439 Free PMC article. Review.
Hereditary retinal diseases are now the leading cause of blindness certification in the working age population (age 16-64 years) in England and Wales, of which retinitis pigmentosa (RP) is the most common disorder. ...
Hereditary retinal diseases are now the leading cause of blindness certification in the working age population (age 16-64 years) in E …
Acupuncture for retinitis pigmentosa: study protocol for a randomised, sham-controlled trial.
Huang H, Wang J, Li H, Lei R, Zou W, Huang Q, Gao N, Zheng Y. Huang H, et al. BMJ Open. 2021 Nov 12;11(11):e049245. doi: 10.1136/bmjopen-2021-049245. BMJ Open. 2021. PMID: 34772749 Free PMC article.
INTRODUCTION: Primary retinitis pigmentosa (RP) is a common hereditary retinal disease in ophthalmology that has a considerable impact on quality of life, but there are few effective therapeutic strategies. ...METHODS AND ANALYSIS: This is a study protocol for a …
INTRODUCTION: Primary retinitis pigmentosa (RP) is a common hereditary retinal disease in ophthalmology that has a considerabl …
Progression of Pentosan-Polysulfate Sodium-Associated Retinopathy: Intermediate Follow-Up.
Leung EH, Levie-Sprick A, Sharma S, Lee GD, Cho H, Yee DC, Mukkamala K. Leung EH, et al. Ophthalmic Surg Lasers Imaging Retina. 2023 Jul;54(7):388-394. doi: 10.3928/23258160-20230522-02. Epub 2023 Jun 1. Ophthalmic Surg Lasers Imaging Retina. 2023. PMID: 37310751

RESULTS: A total of 97 patients were included (33 with PPS-associated retinopathy and 64 without). The average follow-up was 29.4 months, overall cumulative dose was 1,220 910 g (1,730 870 vs 959 910; P < 0.0001), and total PPS duration was 12.1 7.1 years (16.0.2 6.1 vs

…
RESULTS: A total of 97 patients were included (33 with PPS-associated retinopathy and 64 without). The average follow-up was 29.4 mon …
Using crowdsourcing to understand patients attitudes toward a clinical trial for retinitis pigmentosa requiring 4 years of participation.
Kong X, Dorfman C, Trotochaud S, Naufal F, Latkin CA, Campochiaro PA. Kong X, et al. Ophthalmic Genet. 2022 Feb;43(1):36-41. doi: 10.1080/13816810.2021.1961282. Epub 2021 Aug 11. Ophthalmic Genet. 2022. PMID: 34380366 Free PMC article.
BACKGROUND: Clinical trials for retinitis pigmentosa (RP) likely require long follow-ups because of the slow progression of RP. Understanding patients' attitudes toward participation in a long trial and their acceptability of strategies aimed at promot …
BACKGROUND: Clinical trials for retinitis pigmentosa (RP) likely require long follow-ups because of the slow progressio …
Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome.
Genead MA, Fishman GA. Genead MA, et al. Arch Ophthalmol. 2010 Sep;128(9):1146-50. doi: 10.1001/archophthalmol.2010.172. Arch Ophthalmol. 2010. PMID: 20837798 Free PMC article.
OBJECTIVE: To determine the efficacy of sustained topical therapy with dorzolamide hydrochloride, 2%, on visual acuity and cystic macular lesions in patients with retinitis pigmentosa and Usher syndrome. METHODS: In a retrospective case series at a university hospit …
OBJECTIVE: To determine the efficacy of sustained topical therapy with dorzolamide hydrochloride, 2%, on visual acuity and cystic macular le …
A comparison of progressive loss of the ellipsoid zone (EZ) band in autosomal dominant and x-linked retinitis pigmentosa.
Cai CX, Locke KG, Ramachandran R, Birch DG, Hood DC. Cai CX, et al. Invest Ophthalmol Vis Sci. 2014 Oct 23;55(11):7417-22. doi: 10.1167/iovs.14-15013. Invest Ophthalmol Vis Sci. 2014. PMID: 25342618 Free PMC article. Clinical Trial.
PURPOSE: In patients with retinitis pigmentosa (RP), the inner segment ellipsoid zone (EZ; also known as the inner segment/outer segment [IS/OS] border) is a marker of the usable visual field at a given point in time and of the progression of the disease over time. …
PURPOSE: In patients with retinitis pigmentosa (RP), the inner segment ellipsoid zone (EZ; also known as the inner segment/out …
Transcorneal Electrical Stimulation Dose-Dependently Slows the Visual Field Loss in Retinitis Pigmentosa.
Stett A, Schatz A, Gekeler F, Franklin J. Stett A, et al. Transl Vis Sci Technol. 2023 Feb 1;12(2):29. doi: 10.1167/tvst.12.2.29. Transl Vis Sci Technol. 2023. PMID: 36809335 Free PMC article.
PURPOSE: To assess whether transcorneal electrical stimulation (TcES) current-dependently slows progressive loss of visual field area (VFA) in retinitis pigmentosa (RP). METHODS: Data from 51 patients with RP who received monocular TcES treatment once weekly over 1 …
PURPOSE: To assess whether transcorneal electrical stimulation (TcES) current-dependently slows progressive loss of visual field area (VFA) …
20 results